- Report
- May 2024
- 140 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 138 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 139 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 128 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 133 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 129 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 128 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 135 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 133 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- January 2024
- 200 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Report
- January 2023
- 238 Pages
Global
From €2563EUR$2,800USD£2,178GBP
€3662EUR$4,000USD£3,112GBP
- Report
- May 2024
- 136 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 128 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 138 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 140 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 131 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 137 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- January 2025
- 80 Pages
India
From €3204EUR$3,500USD£2,723GBP
- Report
- December 2024
- 85 Pages
Spain
From €3204EUR$3,500USD£2,723GBP
- Report
- August 2024
- 80 Pages
Japan
From €3204EUR$3,500USD£2,723GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more